Allergy drug improves function in patients with chronic injury from multiple sclerosis

Some have you may have spotted this trial result already. It came out a few weeks ago and is reported (as one example) here:

However, what prompted me to post was this review of the trial report, which gives it 5 out of 10. Most significantly it points out the absence of any clinical benefit or even MRI-observable myelin repair.

Still, it may lead to better understanding of what could make myelin repair. But perhaps too early to go out and overdose on antihistamine!


3 Replies

  • Yes, I've been aware of Clemastine Fumarate for some time.

    Forgot all about it in my headlong rush to experiment with 4-ap-3-meoh, et al.

    I'm tempted to give it a go.

  • Hi Chris

    Do you have an idea about the results of the MD1003 (High Dose Pharmaceutical Grade Biotin) trial done by Medday Pharma??


    Like (0)

  • Sorry, I am afraid I don't know anything.

You may also like...